Novartis's shift into high-tech drugs won praise for giving new options to patients but criticism for prices that may run into the millions of dollars as the Swiss drugmaker faced investors at its annual general meeting on Thursday.
from Reuters: Business News https://ift.tt/2NyiPc5
Thursday, February 28, 2019
Home »
business news
,
latest business news
» Novartis faces shareholder criticism over drug prices at AGM
Novartis faces shareholder criticism over drug prices at AGM
Train drivers accept pay deal to end strike action
Aslef said 96.6% of its members who voted backed the deal, marking the end of long-running strikes. from BBC News https://ift.tt/LxCn1G9
0 comments:
Post a Comment